# Study of Probuphine in Patients With Opioid Dependence

> **NCT00772785** · PHASE3 · TERMINATED · sponsor: **Titan Pharmaceuticals** · enrollment: 16 (actual)

## Conditions studied

- Opioid Dependency

## Interventions

- **DRUG:** Probuphine (buprenorphine implant)

## Key facts

- **NCT ID:** NCT00772785
- **Lead sponsor:** Titan Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-09
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** This study was terminated for reasons not related to efficacy or safety
- **Last updated:** 2018-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00772785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00772785, "Study of Probuphine in Patients With Opioid Dependence". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00772785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*